Alex Zhavoronkov, PhD at Lab of the Future March 9 (IMAGE)
Caption
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, is a pioneer in generative AI for novel drug design.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content